Nissay Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $46.9M | Buy |
371,019
+22,333
| +6% | +$2.94M | 0.2% | 77 |
|
|
2026
Q1 | $48.6M | Buy |
348,686
+7,264
| +2% | +$1.02M | 0.26% | 64 |
|
|
2025
Q4 | $41.9M | Buy |
341,422
+14,446
| +4% | +$1.76M | 0.22% | 76 |
|
|
2025
Q3 | $36.3M | Buy |
326,976
+5,043
| +2% | +$573K | 0.2% | 78 |
|
|
2025
Q2 | $35.7M | Buy |
321,933
+10,412
| +3% | +$1.11M | 0.21% | 81 |
|
|
2025
Q1 | $34.9M | Buy |
311,521
+27,278
| +10% | +$2.81M | 0.23% | 73 |
|
|
2024
Q4 | $26.8M | Buy |
284,243
+14,009
| +5% | +$1.26M | 0.16% | 93 |
|
|
2024
Q3 | $22.7M | Buy |
270,234
+21,211
| +9% | +$1.62M | 0.14% | 110 |
|
|
2024
Q2 | $17.1M | Buy |
249,023
+27,046
| +12% | +$1.8M | 0.11% | 120 |
|
|
2024
Q1 | $16.3M | Buy |
221,977
+49,153
| +28% | +$3.78M | 0.11% | 125 |
|
|
2023
Q4 | $14M | Buy |
172,824
+14,049
| +9% | +$1.09M | 0.11% | 119 |
|
|
2023
Q3 | $11.9M | Buy |
158,775
+9,911
| +7% | +$762K | 0.11% | 124 |
|
|
2023
Q2 | $11.5M | Sell |
148,864
-709
| -0.5% | -$56.5K | 0.1% | 128 |
|
|
2023
Q1 | $12.4M | Sell |
149,573
-4,801
| -3% | -$398K | 0.11% | 121 |
|
|
2022
Q4 | $13.3M | Buy |
154,374
+1,347
| +0.9% | +$107K | 0.13% | 116 |
|
|
2022
Q3 | $9.44M | Buy |
153,027
+5,617
| +4% | +$354K | 0.1% | 128 |
|
|
2022
Q2 | $9.11M | Buy |
147,410
+606
| +0.4% | +$37.5K | 0.09% | 128 |
|
|
2022
Q1 | $8.73M | Buy |
146,804
+2,748
| +2% | +$176K | 0.08% | 154 |
|
|
2021
Q4 | $10.5M | Buy |
144,056
+3,182
| +2% | +$219K | 0.08% | 149 |
|
|
2021
Q3 | $9.84M | Sell |
140,874
-3,718
| -3% | -$261K | 0.08% | 141 |
|
|
2021
Q2 | $9.96M | Buy |
144,592
+2,860
| +2% | +$191K | 0.09% | 142 |
|
|
2021
Q1 | $9.16M | Sell |
141,732
-4,015
| -3% | -$259K | 0.09% | 141 |
|
|
2020
Q4 | $8.49M | Sell |
145,747
-7,060
| -5% | -$426K | 0.13% | 138 |
|
|
2020
Q3 | $9.66M | Sell |
152,807
-21,444
| -12% | -$1.49M | 0.16% | 113 |
|
|
2020
Q2 | $13.4M | Buy |
174,251
+8,208
| +5% | +$629K | 0.26% | 95 |
|
|
2020
Q1 | $12.4M | Buy |
166,043
+1,049
| +0.6% | +$72.5K | 0.32% | 84 |
|
|
2019
Q4 | $10.7M | Sell |
164,994
-5,903
| -3% | -$384K | 0.24% | 104 |
|
|
2019
Q3 | $10.8M | Buy |
170,897
+5,396
| +3% | +$353K | 0.26% | 94 |
|
|
2019
Q2 | $11.2M | Sell |
165,501
-6,515
| -4% | -$429K | 0.28% | 89 |
|
|
2019
Q1 | $11.2M | Sell |
172,016
-7,965
| -4% | -$529K | 0.3% | 81 |
|
|
2018
Q4 | $11.3M | Sell |
179,981
-1,634
| -0.9% | -$114K | 0.34% | 72 |
|
|
2018
Q3 | $14M | Sell |
181,615
-30,076
| -14% | -$2.27M | 0.38% | 62 |
|
|
2018
Q2 | $15M | Sell |
211,691
-34,131
| -14% | -$2.41M | 0.44% | 54 |
|
|
2018
Q1 | $18.5M | Sell |
245,822
-22,283
| -8% | -$1.77M | 0.58% | 40 |
|
|
2017
Q4 | $19.2M | Buy |
+268,105
| New | +$20.4M | 0.58% | 43 |
|
Other funds holding GILD
Nissay Asset Management's GILD Position: Q2 2026 in Review
Nissay Asset Management increased its Gilead Sciences (GILD) stake by 6.4% in Q2 2026, buying an estimated $2.94M and bringing the position to 371,019 shares worth $46.9M. The position accounts for 0.2% of the portfolio, ranked #77.
Nissay Asset Management first reported a position in GILD in Q4 2017 and has held it in 35 quarters since. The position peaked at $48.6M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Nissay Asset Management held 371,019 shares of Gilead Sciences worth $46.9M as of Q2 2026.
- Nissay Asset Management bought 22,333 Gilead Sciences shares in Q2 2026, an estimated $2.94M.
- Gilead Sciences made up 0.2% of Nissay Asset Management's portfolio in Q2 2026, its #77 holding.
- Nissay Asset Management first reported a position in Gilead Sciences in Q4 2017 and has held it in 35 quarters since.
- Nissay Asset Management's Gilead Sciences position peaked at $48.6M in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Nissay Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.